These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6255627)

  • 1. Effect of venous occlusion and DDAVP injection on platelet aggregation and platelet cyclic AMP.
    Egberg N
    Thromb Res; 1980 Jul 1-15; 19(1-2):263-5. PubMed ID: 6255627
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet aggregation induced by DDAVP in platelet-type von Willebrand's disease.
    Takahashi H; Nagayama R; Hattori A; Shibata A
    N Engl J Med; 1984 Mar; 310(11):722-3. PubMed ID: 6608051
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
    Holmberg L; Nilsson IM; Borge L; Gunnarsson M; Sjörin E
    N Engl J Med; 1983 Oct; 309(14):816-21. PubMed ID: 6412139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDAVP factor VIII concentrate and its properties in vivo and in vitro.
    Nilsson IM; Mikaelsson M; Vilhardt H; Walter H
    Thromb Res; 1979; 15(1-2):263-71. PubMed ID: 314686
    [No Abstract]   [Full Text] [Related]  

  • 5. Properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) infusion in normal subjects.
    Takahashi H; Itoh M; Kobayashi I; Sakuragawa N; Shibata A
    Tohoku J Exp Med; 1980 Oct; 132(2):133-40. PubMed ID: 6777902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on human platelets.
    Yang X; Disa J; Rao AK
    Thromb Res; 1990 Sep; 59(5):809-18. PubMed ID: 2237837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of vasopressin-induced platelet aggregation.
    Filep J; Rosenkranz B
    Thromb Res; 1987 Jan; 45(1):7-15. PubMed ID: 3105115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation by chlorpropamide of 1-deamino-8-D-arginine vasopressin-induced antidiuresis and stimulation of renal medullary adenylate cyclase and accumulation of adenosine 3',5'-monophosphate.
    Moses AM; Coulson R
    Endocrinology; 1980 Mar; 106(3):967-72. PubMed ID: 6243558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some properties of the human platelet vasopressin receptor.
    Thomas ME; Osmani AH; Scrutton MC
    Thromb Res; 1983 Dec; 32(6):557-66. PubMed ID: 6320489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vasopressin on noradrenaline-induced cyclic AMP accumulation in rat brain slices.
    Hamburger-Bar R; Newman ME
    Pharmacol Biochem Behav; 1985 Feb; 22(2):183-7. PubMed ID: 2984701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of vasopressin aggregation response of human platelets.
    DiTullio NW; Kinter LB; Storer BL
    Thromb Res; 1985 Nov; 40(3):425-32. PubMed ID: 4082118
    [No Abstract]   [Full Text] [Related]  

  • 12. 1-Deamino-8-D-arginine vasopressin and urine cyclic adenosine monophosphate excretion in diabetes insipidus.
    Blackett PR; Seely JR; Altmiller DH; Males JL
    Clin Pharmacol Ther; 1981 Jun; 29(6):793-7. PubMed ID: 6262005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chlorobutanol and DDAVP on whole blood aggregation/clotting.
    Stewart MW; Gordon PA
    Thromb Res; 1991 Dec; 64(6):757-62. PubMed ID: 1798965
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of desmopressin on platelet aggregation defect in systemic amyloidosis: a preliminary report.
    Demiroğlu H; Barişta I; Gürsoy M; Oymak O; Dündar S
    Eur J Haematol; 1996 May; 56(5):283-6. PubMed ID: 8641401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo effects of desmopressin on platelet function.
    Balduini CL; Noris P; Belletti S; Spedini P; Gamba G
    Haematologica; 1999 Oct; 84(10):891-6. PubMed ID: 10509036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor.
    Saito M; Tahara A; Sugimoto T
    Biochem Pharmacol; 1997 Jun; 53(11):1711-7. PubMed ID: 9264324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of des-amino-D-arginine vasopressin (DDAVP) on plasma levels of platelet and endothelial cell release products.
    D'Angelo A; Capitanio A; Smith JB; Valsecchi C; Mannucci PM
    Thromb Haemost; 1983 Feb; 49(1):64-5. PubMed ID: 6687766
    [No Abstract]   [Full Text] [Related]  

  • 18. DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of central diabetes insipidus--mechanism of prolonged antidiuresis.
    Seif SM; Zenser TV; Ciarochi FF; Davis BB; Robinson AG
    J Clin Endocrinol Metab; 1978 Mar; 46(3):381-8. PubMed ID: 221517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the Brattleboro rat in studies of the mechanism by which chlorpropamide enhances the action of vasopressin.
    Moses AM; Fenner R; Schroeder ET; Coulson R
    Ann N Y Acad Sci; 1982; 394():513-7. PubMed ID: 6295230
    [No Abstract]   [Full Text] [Related]  

  • 20. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders.
    Kobrinsky NL; Israels ED; Gerrard JM; Cheang MS; Watson CM; Bishop AJ; Schroeder ML
    Lancet; 1984 May; 1(8387):1145-8. PubMed ID: 6144876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.